A biomimetic receptor for glucose.


Journal

Nature chemistry
ISSN: 1755-4349
Titre abrégé: Nat Chem
Pays: England
ID NLM: 101499734

Informations de publication

Date de publication:
01 2019
Historique:
received: 31 12 2017
accepted: 05 09 2018
pubmed: 14 11 2018
medline: 16 4 2019
entrez: 14 11 2018
Statut: ppublish

Résumé

Specific molecular recognition is routine for biology, but has proved difficult to achieve in synthetic systems. Carbohydrate substrates are especially challenging, because of their diversity and similarity to water, the biological solvent. Here we report a synthetic receptor for glucose, which is biomimetic in both design and capabilities. The core structure is simple and symmetrical, yet provides a cavity which almost perfectly complements the all-equatorial β-pyranoside substrate. The receptor's affinity for glucose, at K

Identifiants

pubmed: 30420776
doi: 10.1038/s41557-018-0155-z
pii: 10.1038/s41557-018-0155-z
doi:

Substances chimiques

Lectins 0
Receptors, Artificial 0
Receptors, Cell Surface 0
glucose receptor 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-56

Auteurs

Robert A Tromans (RA)

School of Chemistry, University of Bristol, Bristol, UK.

Tom S Carter (TS)

Ziylo Ltd., Unit DX, St Philips Central, Bristol, UK.

Laurent Chabanne (L)

Ziylo Ltd., Unit DX, St Philips Central, Bristol, UK.

Matthew P Crump (MP)

School of Chemistry, University of Bristol, Bristol, UK.

Hongyu Li (H)

School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, UK.

Johnathan V Matlock (JV)

Ziylo Ltd., Unit DX, St Philips Central, Bristol, UK.

Michael G Orchard (MG)

Ziylo Ltd., Unit DX, St Philips Central, Bristol, UK.

Anthony P Davis (AP)

School of Chemistry, University of Bristol, Bristol, UK. Anthony.Davis@bristol.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH